Ident. | Authors (with country if any) | Title |
---|
000053 (2014) |
Charlotte I. S. Barker [Royaume-Uni] ; Matthew D. Snape [Royaume-Uni] | Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action |
000063 (2014) |
Surender Khurana [États-Unis] ; Lisa R. King [États-Unis] ; Jody Manischewitz [États-Unis] ; Elizabeth M. Coyle [États-Unis] ; Hana Golding [États-Unis] | Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency |
000064 (2014) |
Carolien E. Van De Sandt [Pays-Bas] ; Joost H. C. M. Kreijtz [Pays-Bas] ; Martina M. Geelhoed-Mieras [Pays-Bas] ; Stella E. Vogelzang-Van Trierum [Pays-Bas] ; Nella J. Nieuwkoop [Pays-Bas] ; David A. M. C. Van De Vijver [Pays-Bas] ; Ron A. M. Fouchier [Pays-Bas] ; Albert D. M. E. Osterhaus [Pays-Bas] ; Bror Morein [Suède] ; Guus F. Rimmelzwaan [Pays-Bas] | Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine |
000066 (2014) |
Rodrigo Jimenez-Garcia [Espagne] ; Cristina Rodriguez-Rieiro [Espagne] ; Valentín Hernandez-Barrera [Espagne] ; Pilar Carrasco Garrido [Espagne] ; Ana Lopez De Andres [Espagne] ; María D. Esteban-Vasallo [Espagne] ; Maria Felicitas Dominguez-Berjon [Espagne] ; Jenaro Astray-Mochales [Espagne] | Negative trends from 2008/9 to 2011/12 seasons in influenza vaccination coverages among high risk subjects and health care workers in Spain |
000067 (2014) |
S. Sohail Ahmed [Italie] ; Peter H. Schur [États-Unis] ; Noni E. Macdonald [Canada] ; Lawrence Steinman [États-Unis] | Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants |
000077 (2014) |
Tara M. Babu [États-Unis] ; Min Levine [États-Unis] ; Theresa Fitzgerald [États-Unis] ; Catherine Luke [États-Unis] ; Mark Y. Sangster [États-Unis] ; HONG JIN [États-Unis] ; David Topham [États-Unis] ; Jacqueline Katz [États-Unis] ; John Treanor [États-Unis] ; Kanta Subbarao [États-Unis] | Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine |
000078 (2014) |
Anna-Karin Maltais [Suède] ; Koert J. Stittelaar [Pays-Bas] ; Edwin J. B. Veldhuis Kroeze [Pays-Bas] ; Geert Van Amerongen [Pays-Bas] ; Marcel L. Dijkshoorn [Pays-Bas] ; Gabriel P. Krestin [Pays-Bas] ; Jorma Hinkula [Suède] ; Hans Arwidsson [Suède] ; Alf Lindberg [Suède] ; Albert D. M. E. Osterhaus [Pays-Bas] | Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets |
000079 (2014) |
A. Morokutti [Autriche] ; T. Muster [Autriche] ; B. Ferko [Autriche] | Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans |
000080 (2014) |
Edgar Turner Overton [États-Unis] ; Paul A. Goepfert [États-Unis] ; Pamela Cunningham [États-Unis] ; William A. Carter [États-Unis] ; Joseph Horvath [États-Unis] ; Diane Young [États-Unis] ; David R. Strayer [États-Unis] | Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans |
000083 (2014) |
Daniela S. Rajao [États-Unis] ; Crystal L. Loving [États-Unis] ; Phillip C. Gauger [États-Unis] ; Pravina Kitikoon [États-Unis] ; Amy L. Vincent [États-Unis] | Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs |
000088 (2014) |
Terho Heikkinen [Finlande] ; Niina Ikonen [Finlande] ; Thedi Ziegler [Finlande] | Impact of Influenza B Lineage-Level Mismatch Between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999-2012 |
000093 (2014) |
Terry Nolan [Australie] ; Patricia Izurieta [Belgique] ; Bee-Wah Lee [Singapour] ; POH CHONG CHAN [Singapour] ; Helen Marshall [Australie] ; Robert Booy [Australie] ; Mamadou Drame [États-Unis] ; David W. Vaughn [Belgique] | Heterologous Prime-Boost Vaccination Using an ASO3B-Adjuvanted Influenza A(H5N1) Vaccine in Infants and Children <3 Years of Age |
000094 (2014) |
YING JU [République populaire de Chine] ; HONGXIA FAN [République populaire de Chine] ; JUN LIU [République populaire de Chine] ; JUN HU [République populaire de Chine] ; XINGHUI LI [République populaire de Chine] ; CHANGFEI LI [République populaire de Chine] ; LIZHAO CHEN [République populaire de Chine] ; QIANG GAO [République populaire de Chine] ; George F. Gao [République populaire de Chine] ; SONGDONG MENG [République populaire de Chine] | Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine |
000096 (2014) |
Lori Winston [États-Unis] ; Stephanie Wagner [États-Unis] ; SHU CHAN [États-Unis] | Healthcare workers under a mandated H1N1 vaccination policy with employment termination penalty: A survey to assess employee perception |
000099 (2014) |
Surender Khurana [États-Unis] ; Elizabeth M. Coyle [États-Unis] ; Swati Verma [États-Unis] ; Lisa R. King [États-Unis] ; Jody Manischewitz [États-Unis] ; Corey J. Crevar [États-Unis] ; Donald M. Carter [États-Unis] ; Ted M. Ross [États-Unis] ; Hana Golding [États-Unis] | H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine |
000102 (2014) |
O. Launay [France] ; P. Y. Boelle [France] ; A. Krivine [France] ; D. Grenet [France] ; V. Boussaud [France] ; N. Remus [France] ; H. Corvol [France] ; F. Chedevergne [France] ; D. Hubert [France] ; I. Sermet-Gaudelus [France] | Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis |
000105 (2014) |
Behnam Nowrouzi-Kia [Canada] ; Allison Mcgeer [Canada] | External cues to action and influenza vaccination among post-graduate trainee physicians in Toronto, Canada |
000106 (2014) |
V. H. Basavaraj [Inde] ; G. Sampath [Inde] ; Nagendra R. Hegde [Inde] ; V. Krishna Mohan [Inde] ; Krishna M. Ella [Inde] | Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies |
000110 (2014) |
Tanya Gottlieb [Israël] ; Tamar Ben-Yedidia [Israël] | Epitope-based approaches to a universal influenza vaccine |
000113 (2014) |
Nagendra R. Hegde [Inde] ; Deepak Kumar [Inde] ; P. Panduranga Rao [Inde] ; P. Krishna Kumari [Inde] ; Yashpal Kaushik [Inde] ; R. Ravikrishnan [Inde] ; Sai D. Prasad [Inde] ; Krishna M. Ella [Inde] | Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India |
000116 (2014) |
Karen M. Hilyard [États-Unis] ; Sandra Crouse Quinn [États-Unis] ; Kevin H. Kim [États-Unis] ; Don Musa [États-Unis] ; Vicki S. Freimuth [États-Unis] | Determinants of Parental Acceptance of the HINI Vaccine |